MICHAEL GRIFFIN: Open Payments
NPI 1710985049 · ABBEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 12 payments from 6 companies in 2025. Trend: 2023 $394 · 2024 $90 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $76 |
| Inspire Medical Systems, Inc. | 2 | $75 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $71 |
| JAZZ PHARMACEUTICALS INC. | 2 | $60 |
| Optinose US, Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
Products named: DUPIXENT, INSPIRE, LUMRYZ, XYWAV, Xhance.
Industry payments across LA — which companies pay providers there.
